Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes

PLoS One. 2021 Mar 16;16(3):e0248009. doi: 10.1371/journal.pone.0248009. eCollection 2021.

Abstract

Introduction: Since the start of the pandemic, millions of people have been infected, with thousands of deaths. Many foci worldwide have been identified in retirement nursing homes, with a high number of deaths. Our study aims were to evaluate the spread of SARS-CoV-2 in the retirement nursing homes, the predictors to develop symptoms, and death.

Methods and findings: We conducted a retrospective study enrolling all people living in retirement nursing homes (PLRNH), where at least one SARS-CoV-2 infected person was present. Medical and clinical data were collected. Variables were compared with Student's t-test or Pearson chi-square test as appropriate. Uni- and multivariate analyses were conducted to evaluate variables' influence on infection and symptoms development. Cox proportional-hazards model was used to evaluate 30 days mortality predictors, considering death as the dependent variable. We enrolled 382 subjects. The mean age was 81.15±10.97 years, and males were 140(36.7%). At the multivariate analysis, mental disorders, malignancies, and angiotensin II receptor blockers were predictors of SARS-CoV-2 infection while having a neurological syndrome was associated with a lower risk. Only half of the people with SARS-CoV-2 infection developed symptoms. Chronic obstructive pulmonary disease and neurological syndrome were correlated with an increased risk of developing SARS-CoV-2 related symptoms. Fifty-six (21.2%) people with SARS-CoV-2 infection died; of these, 53 died in the first 30 days after the swab's positivity. Significant factors associated with 30-days mortality were male gender, hypokinetic disease, and the presence of fever and dyspnea. Patients' autonomy and early heparin treatment were related to lower mortality risk.

Conclusions: We evidenced factors associated with infection's risk and death in a setting with high mortality such as retirement nursing homes, that should be carefully considered in the management of PLRNH.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiotensin Receptor Antagonists / administration & dosage
  • COVID-19 / complications
  • COVID-19 / mortality
  • COVID-19 / pathology*
  • COVID-19 / virology
  • Dyspnea / etiology
  • Female
  • Fever / etiology
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Male
  • Mental Disorders / complications
  • Mental Disorders / pathology
  • Neoplasms / complications
  • Neoplasms / pathology
  • Nursing Homes
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2 / isolation & purification
  • Sex Factors
  • Survival Rate

Substances

  • Angiotensin Receptor Antagonists
  • Heparin, Low-Molecular-Weight

Grants and funding

The authors received no specific funding for this work.